Multiple intrahepatic occupying lesions, most commonly metastatic hepatocellular carcinoma, are mainly seen as malignant tumors of the large intestine. In this case, if treated promptly and effectively, they can survive for 1-2 years, including systemic intravenous chemotherapy and radiofrequency ablation therapy. For isolated intrahepatic lesions with better feeding vessels, hepatic artery cannulation, perfusion chemotherapy and embolization of the hepatic artery can also be chosen, all of which can control tumor progression to some extent. The most common malignant tumor of the intestine is adenocarcinoma, and metastatic tumors of the liver are also predominantly adenocarcinomas. Primary hepatocellular carcinoma is also prone to multiple metastases in the liver. The pathological types include hepatocellular carcinoma and cholangiocellular carcinoma, and the assay of methemoglobin will be significantly increased. If the patient’s condition allows, it can also be controlled by systemic intravenous chemotherapy, and the survival time for patients with advanced stage ranges from 3-6 months.